- Home
- FSBC vs PHAR Comparison
FSBC vs PHAR Comparison
Compare FSBC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- PHAR
- Stock Information
- Founded
- FSBC 2002
- PHAR 1988
- Country
- FSBC United States
- PHAR Netherlands
- Employees
- FSBC N/A
- PHAR N/A
- Industry
- FSBC Banks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- FSBC Finance
- PHAR Health Care
- Exchange
- FSBC Nasdaq
- PHAR Nasdaq
- Market Cap
- FSBC 643.8M
- PHAR 679.0M
- IPO Year
- FSBC 2021
- PHAR N/A
- Fundamental
- Price
- FSBC $29.86
- PHAR $9.10
- Analyst Decision
- FSBC Buy
- PHAR Strong Buy
- Analyst Count
- FSBC 3
- PHAR 3
- Target Price
- FSBC $34.67
- PHAR $27.00
- AVG Volume (30 Days)
- FSBC 35.5K
- PHAR 6.7K
- Earning Date
- FSBC 01-27-2025
- PHAR 03-13-2025
- Dividend Yield
- FSBC 2.65%
- PHAR N/A
- EPS Growth
- FSBC N/A
- PHAR N/A
- EPS
- FSBC 2.25
- PHAR N/A
- Revenue
- FSBC $113,173,000.00
- PHAR $285,745,000.00
- Revenue This Year
- FSBC N/A
- PHAR $20.08
- Revenue Next Year
- FSBC $20.37
- PHAR $9.22
- P/E Ratio
- FSBC $13.44
- PHAR N/A
- Revenue Growth
- FSBC N/A
- PHAR 30.64
- 52 Week Low
- FSBC $21.10
- PHAR $6.65
- 52 Week High
- FSBC $35.13
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- FSBC 44.84
- PHAR 46.44
- Support Level
- FSBC $29.91
- PHAR $9.37
- Resistance Level
- FSBC $30.99
- PHAR $10.01
- Average True Range (ATR)
- FSBC 0.75
- PHAR 0.55
- MACD
- FSBC 0.11
- PHAR -0.14
- Stochastic Oscillator
- FSBC 61.56
- PHAR 16.26
About FSBC Five Star Bancorp
Five Star Bancorp is a California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.